Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate

Chest

Volumn 122, Issue 2, 2002, Pages 618-623

  Fowler, Stephen J ^a   Orr, Linda C ^a   Sims, Erika J ^a   Wilson, Andrew M ^a   Currie, Graeme P ^a   McFarlane, Lesley ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Aerosol propellants; Asthma; Bronchial hyperreactivity; Corticosteroids; Fluticasone

Indexed keywords

CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; METHACHOLINE; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG FORMULATION; FEMALE; FORCED EXPIRATORY VOLUME; GEOMETRY; HUMAN; HYDROCORTISONE URINE LEVEL; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0036036449     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.2.618     Document Type: Article

References (23)

1. Clinical efficacy and safety of fluticasone propionate 250 microgram twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma: French study group
2. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma: International study group
3. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma: U.K. Study group
4. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: Meta-analysis
5. Pharmaceutical transition to non-CFC pressurized metered dose inhalers
6. Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs
7. Safety of inhaled and intranasal corticosteroids: Lessons for the new millennium
8. Differences in lung bioavailability between different propellants for fluticasone propionate
9. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract
10. Standardization of spirometry, 1987 update: Statement of the American Thoracic Society
11. Measurement of airway responsiveness to methacholine: Relative importance of the precision of drug delivery and the method of assessing response
12. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
13. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma
14. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
15. Therapeutic ratio of inhaled corticosteroids in adult asthma: A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function
16. Effectiveness of fluticasone propionate in patients with moderate asthma: A dose-ranging study
17. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis
18. 24 Hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids
19. Measuring the systemic effects of inhaled beclomethasone: Timed morning urine collections compared with 24 hour specimens
20. Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma
21. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects
22. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: A randomised crossover study
23. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate